Highlights DongKoo Bio & Pharma Co., Ltd.

Equities

A006620

KR7006620009

End-of-day quote Korea S.E. Other stock markets 18:00:00 2024-06-06 EDT			5-day change	1st Jan Change
6,680 ^KRW	+0.30%		-0.60%	+18.02%

05-17	Qurient Co., Ltd. announced that it has received KRW 13.499996307 billion in funding from DongKoo Bio & Pharma Co., Ltd.	CI
05-02	Tranche Update on DongKoo Bio & Pharma Co., Ltd.'s Equity Buyback Plan announced on November 2, 2023.	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Tranche Update on DongKoo Bio & Pharma Co., Ltd.'s Equity Buyback Plan announced on November 2, 2023.	05-02	CI
Tranche Update on DongKoo Bio & Pharma Co., Ltd.'s Equity Buyback Plan announced on November 2, 2023.	05-02	CI
DongKoo Bio & Pharma Co., Ltd.'s Equity Buyback announced on November 2, 2023, has expired with 321,701 shares, representing 1.17% for KRW 1,998.73 million.	05-01	CI
Tranche Update on DongKoo Bio & Pharma Co., Ltd.'s Equity Buyback Plan announced on November 2, 2023.	02-02	CI
DongKoo Bio & Pharma Co., Ltd. announces an Equity Buyback for KRW 2,000 million worth of its shares.	11-01	CI
DongKoo Bio&Pharma Co., Ltd. authorizes a Buyback Plan.	11-01	CI
DongKoo Bio & Pharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-20	CI
Tranche Update on DongKoo Bio & Pharma Co., Ltd.'s Equity Buyback Plan announced on January 28, 2022.	22-07-26	CI
Tranche Update on DongKoo Bio & Pharma Co., Ltd.'s Equity Buyback Plan announced on January 28, 2022.	22-07-26	CI
DongKoo Bio & Pharma Co., Ltd.'s Equity Buyback announced on January 28, 2022, has expired with 416,327 shares, representing 1.49% for KRW 2,995.1 million.	22-07-26	CI
Tranche Update on DongKoo Bio&Pharma Co., Ltd.'s Equity Buyback Plan announced on January 28, 2022.	22-04-27	CI
Tranche Update on DongKoo Bio&Pharma Co., Ltd.'s Equity Buyback Plan announced on October 14, 2021.	22-04-12	CI
DongKoo Bio&Pharma Co., Ltd.'s Equity Buyback announced on October 14, 2021, has expired with 251,612 shares, representing 0.89% for KRW 1,997.79 million.	22-04-12	CI
DongKoo Bio&Pharma Co., Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares.	22-01-27	CI
DongKoo Bio&Pharma Co., Ltd. authorizes a Buyback Plan.	22-01-27	CI
DongKoo Bio&Pharma Co., Ltd. announces an Equity Buyback for KRW 2,000 million worth of its shares.	21-10-13	CI
Dongkoo Bio&Pharma Co., Ltd. authorizes a Buyback Plan.	21-10-13	CI
Tranche Update on Dongkoo Bio&Pharma Co., Ltd.'s Equity Buyback Plan announced on August 6, 2019.	19-11-06	CI
Dongkoo Bio&Pharma Co., Ltd.'s Equity Buyback announced on August 6, 2019, has expired with 147,338 shares, representing 1.54% for KRW 1,995.78 million.	19-11-06	CI
Dongkoo Bio&Pharma Co., Ltd. announces an Equity Buyback for KRW 2,000 million worth of its shares.	19-08-06	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights DongKoo Bio & Pharma Co., Ltd.

Equities

A006620

KR7006620009

Highlights

Filters